< Back to situations

[ORGANIZATION]

SNS

Featured in 7 tracked stories · first seen

Situations

[ACTIVE] [POLITICS] [SK]

Slovak National Party election alliance strategy

2 clusters · 3 sources · last updated

Latest: SNS seeks cooperation with Republika party for regional elections

The Slovak National Party (SNS) has shifted its stance regarding political alliances ahead of upcoming elections. Initially, party chairman Andrej Danko rejected the formation of pre-election alliances, stating the party

[ACTIVE] [CRIME] [FR] [BE] [PT]

European phishing, scams and telemarketing consent shifts

29 clusters · 129 sources · last updated

Latest: Portugal authorities issue alerts against widespread phishing and fraud schemes

In late May, Portugal’s tax authority warned of fraudulent emails mimicking IRS amendment requests, while Cabo Verde flagged a fake traffic‑fine notice; France and Spain saw tax‑refund phishing campaigns promising up to

[ACTIVE] [POLITICS] [SK]

SNS political pressure on Slovak Environment Minister

2 clusters · 9 sources · last updated

Latest: SNS nominates Filip Kuffa to replace Tomáš Taraba as Environment Minister

The SNS political party has formally nominated State Secretary Filip Kuffa to replace Tomáš Taraba as the Minister of Environment. SNS leader Andrej Danko stated that the relationship between Taraba and the party has not

[ACTIVE] [POLITICS] [RS] [US] [BA]

Serbia political crisis, elections and aid measures

104 clusters · 378 sources · last updated

Latest: University of Belgrade drops in Shanghai Ranking amid political dispute

Protests sparked by the 2024 Novi Sad railway-station collapse have kept Serbia’s political scene volatile. President Aleksandar Vučić previously pledged to step down after early parliamentary elections, potentially resi

[ACTIVE] [HEALTH] [PT]

Diabetes medication access and costs in Portugal

2 clusters · 9 sources · last updated

Latest: Diabetic patients in Portugal lose access to subsidized medication

In Portugal, the medicines regulator Infarmed authorized the commercialization of generic dapagliflozin, which is 50% cheaper than the brand-name drug Forxiga. This measure aims to treat type 2 diabetes, chronic kidney d

Also covered in